• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跳跃式转移:非小细胞肺癌ⅢA期患者跳跃式转移的临床意义及预后分析

Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.

作者信息

Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I

机构信息

1st Thoracic Surgical Department, General Hospital for Chest Diseases SOTIRIA, 7 P. Dimitrakopoulou Street, 11141 Athens, Greece.

出版信息

Eur J Cardiothorac Surg. 2004 Apr;25(4):502-8. doi: 10.1016/j.ejcts.2004.01.025.

DOI:10.1016/j.ejcts.2004.01.025
PMID:15037262
Abstract

OBJECTIVE

To determine the clinical significance of skip metastases (pN2/S) in patients with resected pIIIA/N2 NSCLC. The incidence of pN2/S after mediastinal lymph node dissection (MLD) and sampling (MLS) were compared.

METHOD

From 1997 to 2000, 580 lung resections for NSCLC performed at our department. The 151 patients (26.5%) at stage IIIA/N2 (pN2+) were grouped according to their skip metastases status. Group A included the ordinary pN2 (pN2/O) cases (71%) and group B the pN2/S (29%). Age, gender, type of resection, right or left lesion, histology, tumor lobe predilection, MLD or MLS pathologic results, the level and the number of node stations involved and survival were analyzed.

RESULTS

In 44 patients (29%) pN2/S disease was present. Statistical analysis revealed significant difference between pN2/O and pN2/S for the following: (1) pN2/S was more common for right-sided lesions (P=0.007); (2) Squamous carcinoma was the main type of pN2/S (P=0.007) and (3) pN2/S was more frequently detected after MLD than after MLS (P=0.001). Although pN2/S involved more often upper mediastinal lymph nodes (Nos. 2, 3) and one station level (pN2/S: 41 vs. pN2/O: 19.6%, P=0.228) was not found statistically significant. pN2/O was more common after right upper lobectomy and pN2/S after right lower lobectomy. The 3-year survival was more favorable for the pN2/S group (A: 24 vs. B: 36%, P=0.07).

CONCLUSION

(1) MLD was found to be more reliable for pN2/S detection than MLS. (2) The presence of pN2/S proved to be a less aggressive form of lymphatic spread that should be taken into account in the future. (3) Strong correlation between right lower lobe tumors and pN2/S was demonstrated. (4) Different routes of cancer lymphatic spread between pN2/S and pN2/O are suggested.

摘要

目的

确定在接受手术切除的IIIA期/N2期非小细胞肺癌(NSCLC)患者中跳跃转移(pN2/S)的临床意义。比较纵隔淋巴结清扫术(MLD)和纵隔淋巴结采样术(MLS)后pN2/S的发生率。

方法

1997年至2000年,我科对580例NSCLC患者实施了肺切除术。将151例IIIA期/N2期(pN2+)患者根据其跳跃转移状态进行分组。A组包括普通pN2(pN2/O)病例(71%),B组为pN2/S病例(29%)。分析了年龄、性别、切除类型、病变位于右侧还是左侧、组织学类型、肿瘤好发肺叶、MLD或MLS的病理结果、受累淋巴结站的水平和数量以及生存率。

结果

44例(29%)患者存在pN2/S病变。统计分析显示pN2/O和pN2/S在以下方面存在显著差异:(1)pN2/S在右侧病变中更常见(P=0.007);(2)鳞状细胞癌是pN2/S的主要类型(P=0.007);(3)MLD后比MLS后更频繁检测到pN2/S(P=0.001)。虽然pN2/S更常累及上纵隔淋巴结(第2、3组),且一个淋巴结站水平(pN2/S:41%对pN2/O:19.6%,P=0.228)未发现有统计学意义。右上叶切除术后pN2/O更常见,右下叶切除术后pN2/S更常见。pN2/S组的3年生存率更有利(A组:24%对B组:36%),P=0.07)。

结论

(1)发现MLD在检测pN2/S方面比MLS更可靠。(2)pN2/S的存在被证明是一种侵袭性较小的淋巴转移形式,未来应予以考虑。(表明右下叶肿瘤与pN2/S之间存在强相关性。(4)提示pN2/S和pN2/O之间存在不同的癌性淋巴转移途径。

相似文献

1
Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.跳跃式转移:非小细胞肺癌ⅢA期患者跳跃式转移的临床意义及预后分析
Eur J Cardiothorac Surg. 2004 Apr;25(4):502-8. doi: 10.1016/j.ejcts.2004.01.025.
2
Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.跳跃式转移至纵隔淋巴结在非小细胞肺癌中的作用。
J Surg Oncol. 2003 Apr;82(4):256-60. doi: 10.1002/jso.10219.
3
Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.非小细胞肺癌中的跳跃转移:N1淋巴结中的预测标志物和孤立肿瘤细胞
Cancer. 2004 May 1;100(9):1909-17. doi: 10.1002/cncr.20165.
4
Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.纵隔淋巴结清扫或取样后ⅢA期非小细胞肺癌的预后
J BUON. 2009 Jan-Mar;14(1):45-9.
5
The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.一站N2期疾病在非小细胞肺癌患者预后中的意义。
Ann Thorac Surg. 2008 Nov;86(5):1626-30. doi: 10.1016/j.athoracsur.2008.07.076.
6
Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.肺癌中N1和N2站之间的边界:下叶肿瘤淋巴结转移模式的经验教训
J Thorac Cardiovasc Surg. 2005 Apr;129(4):825-30. doi: 10.1016/j.jtcvs.2004.06.016.
7
Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.跳跃式纵隔淋巴结转移与肺癌:一个预后较好的特殊N2亚组。
Ann Thorac Surg. 2005 Jan;79(1):225-33. doi: 10.1016/j.athoracsur.2004.06.081.
8
Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.手术切除的N2期非小细胞肺癌的预后因素:纵隔淋巴结转移模式的重要性
Eur J Cardiothorac Surg. 2005 Jul;28(1):33-8. doi: 10.1016/j.ejcts.2005.03.016.
9
Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.N2期非小细胞肺癌手术患者跳跃式淋巴结转移的危险因素分析及其预后价值
Eur J Surg Oncol. 2006 Jun;32(5):583-7. doi: 10.1016/j.ejso.2006.02.004. Epub 2006 Apr 18.
10
Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.根据原发性癌症位置,非小细胞肺癌中淋巴转移扩散的情况。
Lung Cancer. 2004 May;44(2):183-91. doi: 10.1016/j.lungcan.2003.10.012.

引用本文的文献

1
Risk prediction of multiple-station N2 metastasis in patients with upfront surgery for clinical single-station N2 non-small cell lung cancer.术前单站 N2 非小细胞肺癌患者行 upfront 手术时多站 N2 转移的风险预测。
Sci Rep. 2024 Aug 13;14(1):18800. doi: 10.1038/s41598-024-69260-3.
2
Non-adjacent interlobar lymph node metastasis distant from small-sized peripheral non-small cell lung cancer.远离小外周型非小细胞肺癌的非相邻叶间淋巴结转移。
Surg Today. 2022 Dec;52(12):1746-1752. doi: 10.1007/s00595-022-02507-6. Epub 2022 Apr 30.
3
Lymph Node Parameters Predict Adjuvant Chemoradiotherapy Efficacy and Disease-Free Survival in Pathologic N2 Non-Small Cell Lung Cancer.
淋巴结参数可预测病理N2期非小细胞肺癌辅助放化疗疗效及无病生存期
Front Oncol. 2021 Sep 17;11:736892. doi: 10.3389/fonc.2021.736892. eCollection 2021.
4
Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b).小尺寸非小细胞肺癌(T1b)纵隔淋巴结的转移模式
Front Surg. 2020 Sep 22;7:580203. doi: 10.3389/fsurg.2020.580203. eCollection 2020.
5
Correlation between Skip N2 Metastases and SUV, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer.非小细胞肺癌患者 Skip N2 转移与 SUV、肿瘤长径和 Ki67 表达的相关性。
Biomed Res Int. 2020 Apr 25;2020:9298358. doi: 10.1155/2020/9298358. eCollection 2020.
6
Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.中国东部地区 cT1 期肺癌淋巴结转移术前风险评估的回顾性研究。
J Immunol Res. 2019 Dec 1;2019:6263249. doi: 10.1155/2019/6263249. eCollection 2019.
7
The current only location-based nodal classification in NSCLC may be inadequate.目前非小细胞肺癌中仅基于位置的淋巴结分类可能并不充分。
J Thorac Dis. 2019 Aug;11(8):E131-E132. doi: 10.21037/jtd.2019.08.24.
8
Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.在 AJCC N 分期中纳入阳性淋巴结计数可能是 NSCLC 患者预后的更好预测指标,尤其是 III 期患者:一项大型基于人群的研究。
Int J Clin Oncol. 2019 Nov;24(11):1359-1366. doi: 10.1007/s10147-019-01483-1. Epub 2019 Jun 10.
9
Upfront surgery in patients with clinical skip N2 lung cancer based on results of modern radiological examinations.基于现代放射学检查结果对临床跳跃性N2期肺癌患者进行 upfront 手术。 (注:这里“upfront”不太好直接准确翻译,结合语境可理解为“先行的、前期的”等意思,具体准确意思需结合更多医学背景知识确定)
J Thorac Dis. 2018 Dec;10(12):6828-6837. doi: 10.21037/jtd.2018.10.115.
10
Clinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer.N2期非小细胞肺癌纵隔淋巴结跳跃转移的临床意义
J Thorac Dis. 2018 Mar;10(3):1683-1688. doi: 10.21037/jtd.2018.01.176.